Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas”

1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,756
Index total 30,257
Page 29 / 74

Quick answer

This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,756 results for “The Board of Regents of the University of Texas” · 30,257 patents in full index Clear search

  1. US 10207013

    Gadolinium-based contrast agents for sensitive detection of Zn2+ with MRI

    The Board of Regents of the University of Texas System · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  2. US 10208012

    Compounds for treating inflammatory and hyperproliferative diseases

    The Board of Regents of the University of Texas System · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  3. US 10201554

    Esters of 2-deoxy-monosacharides with anti proliferative activity

    The Board of Regents of the University of Texas System · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  4. US 10195297

    Iron garnet nanoparticles for cancer radiotherapy and chemotherapy

    The Board of Regents of the University of Texas System · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  5. US 10196450

    Anti-OX40 antibodies and methods of using the same

    The Board of Regents of the University of Texas System · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  6. US 10183011

    Anti-depression compounds

    The Board of Regents of the University of Texas System · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  7. US 10183972

    BK channel-modulating peptides and their use

    The Board of Regents of the University of Texas System · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  8. US 10182997

    Liposomal curcumin for treatment of cancer

    The Board of Regents of the University of Texas System · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  9. US 10172827

    Pro-neurogenic compounds

    The Board of Regents of the University of Texas System · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  10. US 10168337

    Method and biomarkers for the detection of dengue hemorrhagic fever

    The Board of Regents of the University of Texas System · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  11. US 10167259

    Allosteric inhibitors of proteasome and methods of use thereof

    The Board of Regents of the University of Texas System · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  12. US 10167337

    Combination immunotherapy for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  13. US 10159765

    Tissue engineered devices and methods for making same

    The Board of Regents of the University of Texas System · Granted Dec 25, 2018 · Expires Dec 20, 2038

    granted

  14. US 10154669

    Improving color and release profile of resin compositions comprising silver nanoparticles

    The Board of Regents of the University of Texas System · Granted Dec 18, 2018 · Expires Dec 13, 2038

    granted

  15. US 10155003

    Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes, or cancer

    The Board of Regents of the University of Texas System · Granted Dec 18, 2018 · Expires Dec 13, 2038

    granted

  16. US 10150753

    Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyrdin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamide

    The Board of Regents of the University of Texas System · Granted Dec 11, 2018 · Expires Dec 6, 2038

    granted

  17. US 10149836

    Isoxazole treatments for frontotemporal dementia

    The Board of Regents of the University of Texas System · Granted Dec 11, 2018 · Expires Dec 6, 2038

    granted

  18. US 10143658

    Multistage delivery of active agents

    The Board of Regents of the University of Texas System · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted

  19. US 10125128

    GLS1 inhibitors for treating disease

    The Board of Regents of the University of Texas System · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted

  20. US 10126309

    Method for the detection of an albumin isoform

    The Board of Regents of the University of Texas System · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted

  21. US 10125193

    Chimeric antigen receptors and methods of making

    The Board of Regents of the University of Texas System · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted

  22. US 10117878

    Ligands for nematode nuclear receptors and uses thereof

    The Board of Regents of the University of Texas System · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  23. US 10098971

    Library of pH responsive polymers and nanoprobes thereof

    The Board of Regents of the University of Texas System · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted

  24. US 10098878

    HIF-2α inhibitors for treating iron overload disorders

    The Board of Regents of the University of Texas System · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.